Loading company…
Zebi AI Therapeutics developed machine learning tools for protein and molecule research in drug development.
Zebi AI Therapeutics developed machine learning programs and algorithms to study interactions between proteins and molecules for therapeutic drug development and manufacturing. Founded in 2019, it is based in the US and is at Seed stage. Relay Therapeutics acquired it for USD 85 million in April 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in